To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
(NASDAQ:CLFD), a leader in fiber connectivity solutions for broadband, data center, and network infrastructure environments, today announced the launch of the NOVA Platform, a modular, high-density ...
About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...
Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antib ...
Midia Research has teamed up with music-creation platform Splice to publish a 'Sounds of 2026' report tracking trends.
Splice named Afro House its top genre of 2025 after a 778% download increase, according to the platform's newly released Sounds of 2026 trend report.
AFL, an industry-leading manufacturer of fiber optic cables, connectivity, equipment and related services, announces the launch of the Fujikura 100S Fusion Splicer and CT60 Fiber Cleaver. These ...
The first patient has been treated in Oxford in the second phase of an international clinical trial testing a.
La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...
SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...
From the moment the eight-minute video about the suspect fundraising methods used by President Nikos Chrisodoulides’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback